Jardine Matheson acquires I-MED Radiology
Analysis based on 13 articles · First reported May 25, 2026 · Last updated May 25, 2026
The acquisition of I-MED Radiology Network>>> by Jardines (company)>>> is expected to be neutral to Jardines (company)>>>'s underlying earnings per share in the first full year, becoming accretive thereafter. This strategic move diversifies Jardines (company)>>>'s portfolio into the growing healthcare diagnostics sector, potentially boosting its long-term market value.
Jardines (company)>>> has agreed to acquire I-MED Radiology Network>>>, an Australian medical imaging provider, for a total enterprise value of A$3.4 billion ($2.4 billion). The deal includes I-MED Radiology Network>>>'s minority interest in Harrison.ai>>>, a firm developing radiology AI solutions. This acquisition, funded through cash reserves and debt, marks Jardines (company)>>>'s expansion into the healthcare diagnostics business, aligning with its strategy to invest in market-leading businesses and growth areas. I-MED Radiology Network>>> operates 215 diagnostic imaging clinics across Australia>>> and New Zealand>>>, performing over 7 million procedures annually, and also provides teleradiology services in Australia>>>, New Zealand>>>, and the United States>>>. The transaction is subject to regulatory approvals and is expected to close later in 2026. Jardines (company)>>>'s CEO, Lincoln Pan>>>, stated that the business is expected to expand further in its core and new markets. The deal values I-MED Radiology Network>>> at about 11.5 times forecast adjusted EBITDA for the year ending June 2026, excluding the Harrison.ai>>> stake.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard